Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apher (Q67231482)
Jump to navigation
Jump to search
scientific article published on 01 August 1988
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apher |
scientific article published on 01 August 1988 |
Statements
Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apheresis (English)
H Mabuchi
H Fujita
I Michishita
M Takeda
K Kajinami
J Koizumi
R Takeda
T Takegoshi
T Wakasugi
1 August 1988